New research reveals that individuals who come off popular weight-loss injections like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who halt traditional diet and exercise regimens.
Research printed in a leading health publication demonstrates that while obese individuals often shed a large proportion of their total mass while using the jabs, the mass comes back at an average rate of 0.8 kg per month once they quit.
"People buying these medications must be cognizant of the danger of quick rebound weight gain when the treatment concludes," stated expert Dr. Susan Jebb.
That rate of recovery means a return to pre-treatment weight within about a year and a half.
Comparing Therapies
The study, which reviewed dozens of trials involving thousands of patients, contrasted the results of GLP-1 agonists with conventional dieting.
Researchers point out that people who lose weight through diet and exercise generally see a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Explaining the Fast Regain
Nutrition scientists believe the mechanism of the injections explains the heightened rebound.
GLP-1 drugs copy a body's own chemical called GLP-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production could lead to the system to produce less of its endogenous hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this hormone supplement results in hunger is no longer kept in check, making binge eating much more probable."
A Lifelong Condition?
Health authorities recommend the injections for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.
A number of clinicians argue that, due to the likelihood of weight regain, the treatment is often life-long.
This perspective is reinforced by pharmaceutical companies, who state that the findings "highlight the persistent nature of obesity," comparing it to managing conditions like high blood pressure.
Patient Accounts
Users who have come off the jabs describe a intense return of appetite.
"It felt as if something flipping and I was suddenly ravenous," described an individual.
The struggle is exacerbated if patients have not developed lasting dietary or behavioural modifications during treatment.
Growing Interest
Figures suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.
- Adoption is more common among women compared to men.
- The middle-aged age group shows the highest level of interest.
- Many obtain the medications through private healthcare rather than the NHS.
Finally, experts stress that while the jabs are powerful tools for shedding pounds, they are not a magic fix and maintained weight loss likely depends on ongoing behavioural changes.
